Effect of proinflammatory cytokines, tumor necrosis factor-α and interferon-γ on epithelial barrier function and matrix metalloproteinase-9 in madin darby canine kidney cells

Cellular Physiology and Biochemistry

Volumn 19, Issue 1-4, 2007, Pages 99-112

  Leone, Amanda K ^a   Chun, Jennifer A ^b   Koehler, Christopher L ^b   Caranto, Jonathan ^b   King, Jonathan M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TRINITY UNIVERSITY   (United States)

Author keywords

Epithelial barrier; Matrix metalloproteinase; MDCK cells; MMP 9 gene expression; Tumor necrosis factor ; Zymography

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; EPITHELIUM CELL; KIDNEY CELL; KIDNEY EPITHELIUM; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 33847010257     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099198     Document Type: Article

References (54)

1. Schneeberger EE, Lynch RD: The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004:286(6):C1213-1228.
2. Cereijido M, Shoshani L, Contreras RG: Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity. Am J Physiol Gastrointest Liver Physiol 2000;279(3):G477-482.
3. Balkovetz DF: Claudins at the gate: determinants of renal epithelial tight junction paracellular permeability. Am J Physiol Renal Physiol 2006;290(3):F572-579.
4. Lee DB, Huang E, Ward HJ: Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 2006;290(1):F20-34.
5. Somerville RP, Oblander SA, Apte SS: Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003;4(6):216.
6. Chang C, Werb Z: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001;11(11):S37-43.
7. Murphy G, Cawston TE, Reynolds JJ: An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J 1981;195(1):167-170.
8. Cambray GJ, Murphy G, Reynolds JJ: The effects of dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage explants from the joints of rabbits with a proliferative arthritis. Rheumatol Int 1981;1(2):69-72.
9. Sellers A, Meikle MC, Reynolds JJ: Collagenase and collagenase inhibitor levels following changes in bone resorption in vitro. Calcif Tissue Int 1980;31(1):35-43.
10. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000;15(9):1379-1383.
11. Zaoui P, Cantin JF, Alimardani-Bessette M, Monier F, Halimi S, Morel F, Cordonnier D: Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions. Diabetes Metab 2000;26 Suppl 4:25-29.
12. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996;97(4):1094-1101.
13. Rankin CA, Suzuki K, Itoh Y, Ziemer DM, Grantham JJ, Calvet JP, Nagase H: Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules. Kidney Int 1996;50(3):835-844.
14. Ebihara I, Nakamura T, Tomino Y, Shimada N, Koide H: Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Am J Nephrol 1998;18(4):305-310.
15. Yokoyama H, Wada T, Kobayashi K, Kuno K, Kurihara H, Shindo T, Matsushima K: A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 null mutant mice develop renal lesions mimicking obstructive nephropathy. Nephrol Dial Transplant 2002;17 Suppl 9:39-41.
16. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K: Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997;272(1):556-562.
17. Medina C, Videla S, Radomski A, Radomski MW, Antolin M, Guarner F, Vilaseca J, Salas A, Malagelada JR: Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis. Am J Physiol Gastrointest Liver Physiol 2003;284(1):G116-122.
18. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH: Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21(19):7724-7732.
19. Mori T, Wang X, Aoki T, Lo EH: Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma 2002;19(11):1411-1419.
20. Alexander JS, Elrod JW: Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat 2002;200(6):561-574.
21. Ismair MG, Ries C, Lottspeich F, Zang C, Kolb HJ, Petrides PE: Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1. Leukemia 1998;12(7):1136-1143.
22. Pagenstecher A, Stalder AK, Kincaid CL, Volk B, Campbell IL: Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharideinduced endotoxemia in mice. Am J Pathol 2000;157(1):197-210.
23. Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10(6):415-433.
24. Campbell SE, Nasir L, Argyle DJ, Bennett D: Molecular cloning and characterization of canine metalloproteinase-9 gene promoter. Gene 2001;273(1):81-87.
25. Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM: Proinflammatory cytokines tumor necrosis factor-alpha and interferongamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 2006;6(1):2.
26. Knight CG, Willenbrock F, Murphy G: A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992;296(3):263-266.
27. Chang YS, Munn LL, Hillsley MV, Dull RO, Yuan J, Lakshminarayanan S, Gardner TW, Jain RK, Tarbell JM: Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. Microvasc Res 2000;59(2):265-277.
28. Ramesh G, Reeves WB: TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110(6):835-842.
29. Gan X, Wong B, Wright SD, Cai TQ: Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli. J Interferon Cytokine Res 2001;21(2):93-98.
30. Piedagnel R, Murphy G, Ronco PM, Lelongt B: Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J Biol Chem 1999;274(3):1614-1620.
31. Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, Sato H: Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 2001;276(30):28204-28211.
32. Solorzano CC, Ksontini R, Pruitt JH, Hess PJ, Edwards PD, Kaibara A, Abouhamze A, Auffenberg T, Galardy RE, Vauthey JN, Copeland EM, 3rd, Edwards CK, 3rd, Lauwers GY, Clare-Salzler M, MacKay SL, Moldawer LL, Lazarus DD: Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J Immunol 1997;158(1):414-419.
33. Monea S, Lehti K, Keski-Oja J, Mignatti P: Plasmin activates pro-matrix metalloproteinase-2 with a membranetype 1 matrix metalloproteinase-dependent mechanism. J Cell Physiol 2002;192(2):160-170.
34. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY: MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 2001;263(2):209-223.
35. Fridman R, Toth M, Pena D, Mobashery S: Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 1995;55(12):2548-2555.
36. Rundhaug JE: Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005, 9(2):267-285.
37. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP: Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274(19):13066-13076.
38. DeClerck YA, Laug WE: Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Enzyme Protein 1996;49(1-3):72-84.
39. Yeo SJ, Kim SJ, Kim JH, Lee HJ, Kook YH: Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells. Arch Virol 1999;144(7):1361-1370.
40. Ma Z, Qin H, Benveniste EN: Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 2001;167(9):5150-5159.
41. Nee LE, McMorrow T, Campbell E, Slattery C, Ryan MP: TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int 2004;66(4):1376-1386.
42. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M: Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NFkappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol 2001;281(6):L1444-1452.
43. Lacherade JC, Van De Louw A, Planus E, Escudier E, D'Ortho MP, Lafuma C, Harf A, Delclaux C: Evaluation of basement membrane degradation during TNFalpha-induced increase in epithelial permeability. Am J Physiol Lung Cell Mol Physiol 2001;281(1):L134-143.
44. Pacheco MM, Nishimoto IN, Mourao Neto M, Mantovani EB, Brentani MM: Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis. Int J Biol Markers 2001;16(1):62-68.
45. Liu S, Liang Y, Huang H, Wang L, Li Y, Li J, Li X, Wang H: ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta1 stimulated glomerular podocytes. Cell Physiol Biochem 2005;16(4-6):207-216.
46. Bai Y, Wang L, Li Y, Liu S, Li J, Wang H, Huang H: High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol Biochem 2006;17(1-2):57-68.
47. Wachtel M, Frei K, Ehler E, Fontana A, Winterhalter K, Gloor SM: Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci 1999;112 ( Pt 23):4347-4356.
48. Bojarski C, Weiske J, Schoneberg T, Schroder W, Mankertz J, Schulzke JD, Florian P, Fromm M, Tauber R, Huber O: The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci 2004;117(Pt 10):2097-2107.
49. Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE: Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am J Respir Cell Mol Biol 2004;30(6):761-770.
50. Carrozzino F, Soulie P, Huber D, Mensi N, Orci L, Cano A, Feraille E, Montesano R: Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol 2005;289(4):C1002-1014.
51. Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A: Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 2005;118(Pt 15):3371-3385.
52. Covington MD, Bayless KJ, Burghardt RC, Davis GE, Parrish AR: Ischemiainduced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases. Am J Physiol Renal Physiol 2005;289(2):F280-288.
53. Covington MD, Burghardt RC, Parrish AR: Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 2006;290(1):F43-51.
54. Fiorino AS, Zvibel I: Disruption of cell-cell adhesion in the presence of sodium butyrate activates expression of the 92 kDa type IV collagenase in MDCK cells. Cell Biol Int 1996;20(7):489-499.